Not all patients with CLL involve therapy. Irrespective of all the latest advances, the iwCLL still recommends watchful observation for patients with asymptomatic condition.86 This recommendation is based on at the very least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Nah berbicara https://linkalternatifmbl7766433.fare-blog.com/33229716/the-ultimate-guide-to-mbl77